Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › MSLE
SPHERA FUNDS MANAGEMENT LTD. position in MSLE
SATELLOS BIOSCIENCE INC · Health Care
SPHERA FUNDS MANAGEMENT LTD. reported holding 652,590 shares of MSLE (SATELLOS BIOSCIENCE INC) in its Q2 2026 13F filing — a position valued at US$5.1M, representing 0.71% of its reported portfolio and ranking #48 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SPHERA FUNDS MANAGEMENT LTD.'s MSLE position evolved
SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in MSLE in Q1 2026 at 489,207 shares (US$2.8M). The position peaked in Q2 2026 at 652,590 shares, worth US$5.1M. Across 2 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 652,590 shares valued at US$5.1M — an increase of 163,383 shares quarter over quarter.. Notable position changes include a 33% increase in Q2 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 489.21K | $2.75M | New |
| Q2 2026 | 652.59K | $5.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MSLE and 13F data
MSLE (SATELLOS BIOSCIENCE INC) is a Health Care company. 27 other funds we track also report a position in MSLE — the largest reported positions include Vivo Capital, LLC (US$6.3M), Stonepine Capital Management, LLC (US$3.7M), Avidity Partners Management LP (US$3.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MSLE
- Vivo Capital, LLC 813.67K sh · $6.33M · Q2 2026
- Stonepine Capital Management, LLC 491.62K sh · $3.72M · Q2 2026
- Avidity Partners Management LP 387.77K sh · $3.01M · Q2 2026
- Saturn V Capital Management LP 350.00K sh · $2.72M · Q2 2026
- Empery Asset Management, LP 107.10K sh · $832.70K · Q2 2026
More on SPHERA FUNDS MANAGEMENT LTD.
FAQ
How long has SPHERA FUNDS MANAGEMENT LTD. held MSLE?
SPHERA FUNDS MANAGEMENT LTD. has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in MSLE?
As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 652.59K shares of MSLE (SATELLOS BIOSCIENCE INC), valued at $5.07M, representing 0.71% of its reported portfolio and ranking #48.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling MSLE?
In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in MSLE. The position peaked in Q2 2026 at 652.59K shares.
Which other funds hold MSLE?
Other major institutional holders of MSLE include Vivo Capital, LLC, Stonepine Capital Management, LLC, Avidity Partners Management LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.